Matthew David

2022

In 2022, Matthew David earned a total compensation of $1.1M as Executive Vice President and Chief Financial Officer at CorMedix, a 20% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$389,485
Option Awards$305,900
Salary$393,462
Other$47,697
Total$1,136,544

David received $393.5K in salary, accounting for 35% of the total pay in 2022.

David also received $389.5K in non-equity incentive plan, $305.9K in option awards and $47.7K in other compensation.

Rankings

In 2022, Matthew David's compensation ranked 2,791st out of 5,756 executives tracked by ExecPay. In other words, David earned more than 51.5% of executives.

ClassificationRankingPercentile
All
2,791
out of 5,756
52nd
Division
Manufacturing
1,553
out of 3,133
50th
Major group
Chemicals And Allied Products
720
out of 1,419
49th
Industry group
Drugs
672
out of 1,320
49th
Industry
Pharmaceutical Preparations
486
out of 966
50th
Source: SEC filing on September 13, 2023.

David's colleagues

We found four more compensation records of executives who worked with Matthew David at CorMedix in 2022.

2022

Joseph Todisco

CorMedix

Chief Executive Officer

2022

Phoebe Mounts

CorMedix

General Counsel

2022

Thomas Nusbickel

CorMedix

Former Chief Commercial Officer

2022

Elizabeth Hurlburt

CorMedix

Executive Vice President and Head of Clinical Operations

News

You may also like